Investigating the role of targeting stromal MAOA in the immune microenvironment of prostate cancer based on a humanized mouse model of two individuals
DOI:
CSTR:
Author:
Affiliation:

1.Department of Urology, Xijing Hospital, Air Force Medical University;2.Laboratory Animal Center, Air Force Medical University

Clc Number:

Fund Project:

Funded by the National Natural Science Foundation of China (32070532);The First Affiliated Hospital of Air Force Military Medical University Aviation Clinical Medicine Special Research Project (HKLCZX03)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    【】Objective By constructing an immune-tumor dual humanized mouse model, explore the role of targeting monoamine oxidase A (MAOA) in the immune microenvironment of prostate cancer. Methods Utilize bioinformatics analysis to examine the relationship between MAOAhigh cancer-associated fibroblasts (CAFs) and T cells in prostate cancer; employ multiplex immunofluorescence to analyze the relationship between stromal MAOA and CD8+ T cells; construct an immune-tumor dual humanized mouse model to in vivo verify the infiltration of CD8+ T cells after targeting stromal MAOA. Results The expression of MAOA in the stroma is inversely proportional to the infiltration of CD8+ T cells; inhibiting MAOA in the stroma can enhance the infiltration of CD8+ T cells in vivo, which may be achieved by suppressing the accumulation of collagen in the tumor microenvironment. Conclusion Stromal MAOA plays an important role in the immunosuppressive microenvironment of prostate cancer, and inhibiting stromal MAOA can promote the infiltration of immune cells. MAOA inhibitors may serve as potential therapeutic drugs for immune combination therapy in patients with prostate cancer

    Reference
    Related
    Cited by
Get Citation
Related Videos

Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:October 09,2024
  • Revised:December 27,2024
  • Adopted:May 19,2025
  • Online:
  • Published:
Article QR Code